Literature DB >> 25628783

Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes.

Paul W Burridge1, Scott A Metzler2, Karina H Nakayama3, Oscar J Abilez4, Chelsey S Simmons5, Marc A Bruce6, Yuka Matsuura4, Paul Kim4, Joseph C Wu1, Manish Butte6, Ngan F Huang3, Phillip C Yang1.   

Abstract

Therapeutic delivery of cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represents a novel clinical approach to regenerate the injured myocardium. However, poor survival and contractility of these cells are a significant bottleneck to their clinical use. To better understand the role of cell-cell communication in enhancing the phenotype and contractile properties of hPSC-CMs, we developed a three-dimensional (3D) hydrogel composed of hPSC-CMs, human pluripotent stem cell-derived endothelial cells (hPSC-ECs), and/or human amniotic mesenchymal stem cells (hAMSCs). The objective of this study was to examine the role of multi-cellular interactions among hPSC-ECs and hAMSCs on the survival and long-term contractile phenotype of hPSC-CMs in a 3D hydrogel. Quantification of spontaneous contractility of hPSC-CMs in tri-culture demonstrated a 6-fold increase in the area of contractile motion after 6 weeks with characteristic rhythmic contraction frequency, when compared to hPSC-CMs alone (P < 0.05). This finding was supported by a statistically significant increase in cardiac troponin T protein expression in the tri-culture hydrogel construct at 6 weeks, when compared to hPSC-CMs alone (P < 0.001). The sustained hPSC-CM survival and contractility in tri-culture was associated with a significant upregulation in the gene expression of L-type Ca(2+) ion channel, Cav1.2, and the inward-rectifier potassium channel, Kir2.1 (P < 0.05), suggesting a role of ion channels in mediating these processes. These findings demonstrate that multi-cellular interactions modulate hPSC-CM phenotype, function, and survival, and they will have important implications in engineering cardiac tissues for treatment of cardiovascular diseases.

Entities:  

Keywords:  Induced pluripotent stem cell; cardiac patch; cardiomyocyte; differentiation; endothelial cell; mesenchymal stem cell

Year:  2014        PMID: 25628783      PMCID: PMC4297340     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  25 in total

1.  Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Authors:  Oren Caspi; Ayelet Lesman; Yaara Basevitch; Amira Gepstein; Gil Arbel; Irit Huber Manhal Habib; Lior Gepstein; Shulamit Levenberg
Journal:  Circ Res       Date:  2007-01-11       Impact factor: 17.367

Review 2.  Endothelial-cardiomyocyte interactions in cardiac development and repair.

Authors:  Patrick C H Hsieh; Michael E Davis; Laura K Lisowski; Richard T Lee
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

3.  Three-dimensional culture alters primary cardiac cell phenotype.

Authors:  Robert E Akins; Danielle Rockwood; Karyn G Robinson; Daniel Sandusky; John Rabolt; Christian Pizarro
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

4.  Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts.

Authors:  Hidekazu Sekine; Tatsuya Shimizu; Kyoko Hobo; Sachiko Sekiya; Joseph Yang; Masayuki Yamato; Hiromi Kurosawa; Eiji Kobayashi; Teruo Okano
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

5.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

6.  Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.

Authors:  Jeanette Beers; Daniel R Gulbranson; Nicole George; Lauren I Siniscalchi; Jeffrey Jones; James A Thomson; Guokai Chen
Journal:  Nat Protoc       Date:  2012-10-25       Impact factor: 13.491

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Atomic force mechanobiology of pluripotent stem cell-derived cardiomyocytes.

Authors:  Jianwei Liu; Ning Sun; Marc A Bruce; Joseph C Wu; Manish J Butte
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  2D and 3D-organized cardiac cells shows differences in cellular morphology, adhesion junctions, presence of myofibrils and protein expression.

Authors:  Carolina Pontes Soares; Victor Midlej; Maria Eduarda Weschollek de Oliveira; Marlene Benchimol; Manoel Luis Costa; Cláudia Mermelstein
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 10.  The advancing field of cell-based therapy: insights and lessons from clinical trials.

Authors:  Kartik S Telukuntla; Viky Y Suncion; Ivonne H Schulman; Joshua M Hare
Journal:  J Am Heart Assoc       Date:  2013-10-10       Impact factor: 5.501

View more
  25 in total

1.  Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells.

Authors:  Maureen Wanjare; Luqia Hou; Karina H Nakayama; Joseph J Kim; Nicholas P Mezak; Oscar J Abilez; Evangeline Tzatzalos; Joseph C Wu; Ngan F Huang
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

2.  Phenotypic Variation Between Stromal Cells Differentially Impacts Engineered Cardiac Tissue Function.

Authors:  Tracy A Hookway; Oriane B Matthys; Federico N Mendoza-Camacho; Sarah Rains; Jessica E Sepulveda; David A Joy; Todd C McDevitt
Journal:  Tissue Eng Part A       Date:  2019-05       Impact factor: 3.845

3.  Inspiration from heart development: Biomimetic development of functional human cardiac organoids.

Authors:  Dylan J Richards; Robert C Coyle; Yu Tan; Jia Jia; Kerri Wong; Katelynn Toomer; Donald R Menick; Ying Mei
Journal:  Biomaterials       Date:  2017-07-12       Impact factor: 12.479

Review 4.  Regulation of the microenvironment for cardiac tissue engineering.

Authors:  Maureen Wanjare; Ngan F Huang
Journal:  Regen Med       Date:  2017-02-17       Impact factor: 3.806

Review 5.  Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?

Authors:  Maribella Domenech; Lilliana Polo-Corrales; Jaime E Ramirez-Vick; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2016-07-21       Impact factor: 6.389

6.  Neural Differentiation of Spheroids Derived from Human Induced Pluripotent Stem Cells-Mesenchymal Stem Cells Coculture.

Authors:  Liqing Song; Ang-Chen Tsai; Xuegang Yuan; Julie Bejoy; Sébastien Sart; Teng Ma; Yan Li
Journal:  Tissue Eng Part A       Date:  2018-01-03       Impact factor: 3.845

7.  Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes.

Authors:  Xiefan Fang; Ryan R Poulsen; John Wang-Hu; Olivia Shi; Nicholas S Calvo; Chelsey S Simmons; Scott A Rivkees; Christopher C Wendler
Journal:  FASEB J       Date:  2016-06-15       Impact factor: 5.191

8.  Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells.

Authors:  Giulia Campostrini; Viviana Meraviglia; Elisa Giacomelli; Ruben W J van Helden; Loukia Yiangou; Richard P Davis; Milena Bellin; Valeria V Orlova; Christine L Mummery
Journal:  Nat Protoc       Date:  2021-03-26       Impact factor: 13.491

Review 9.  Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Authors:  Yosuke K Kurokawa; Steven C George
Journal:  Adv Drug Deliv Rev       Date:  2015-07-23       Impact factor: 15.470

Review 10.  Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach.

Authors:  Ning-Ning Guo; Li-Ping Liu; Yun-Wen Zheng; Yu-Mei Li
Journal:  World J Stem Cells       Date:  2020-01-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.